title: Volume Overload in Heart Failure: An Evidence-Based Review of Strategies for Treatment and Prevention.
abstract: Acute decompensated heart failure is the leading cause of hospital admission in the United States, with a high risk of readmission within 30 days. Most acute decompensated heart failure admissions are driven by congestive signs and symptoms resulting from fluid and sodium overload. We reviewed the evidence base addressing the management and prevention of fluid overload in heart failure, focusing on recent clinical trials. All the references in this review were obtained through PubMed and had at least 1 of the following key words: heart failure and volume overload, congestion, loop diuretics, thiazide diuretics, aldosterone antagonists, dopamine, cardiorenal syndrome, nesiritide, vasopressin antagonists, ultrafiltration, sodium restriction, fluid restriction, telemonitoring, and invasive hemodynamic monitoring. We also reviewed relevant references cited in the obtained articles, especially articles addressing methods of treating or preventing volume overload in patients with heart failure.
authors.affiliation: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Brian A
authors.initials: BA
authors.lastname: Houston
authors.affiliation: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Rohan J
authors.initials: RJ
authors.lastname: Kalathiya
authors.affiliation: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Kim
authors.affiliation: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: szakari2@jhmi.edu.
authors.forename: Sammy
authors.initials: S
authors.lastname: Zakaria
mesh_terms: D000208:Acute Disease; D002316:Cardiotonic Agents / Q000627:therapeutic use; D019468:Disease Management; D018450:Disease Progression; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D045283:Natriuretic Agents / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
chemical_list: D002316:Cardiotonic Agents; D045283:Natriuretic Agents